vimarsana.com

Page 51 - குறைந்தபட்சம் ஆக்கிரமிப்பு அறுவை சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nikki Heider and Jennifer Regan, Author at MedCity News

Nikki Heider and Jennifer Regan Nikki Heider is a senior marketing manager at Welltok with more than 15 years of experience in healthcare marketing. Prior to Welltok, Nikki served as marketing/PR manager at Denver Public Health, and as a service line marketing manager at Children’s Hospital Colorado, Boston Children’s Hospital and Dana-Farber Cancer Institute. She has a wealth of communications and public health knowledge which she enjoys applying to marketing solutions in the healthcare industry. Jennifer Regan is Director of Consumer Engagement, Capital District Physicians’ Health Plan Inc. (CDPHP)Jennifer joined CDPHP in 2019 and leads the team responsible for developing, promoting, refining, and analyzing a wide array

Amazon, Crossover Health expand primary care partnership to two more states

Prometheus Bio s IPO raises $190M for inflammatory bowel disease R&D

Prometheus Biosciences is taking a precision medicine approach to developing drugs and diagnostics for inflammatory bowel disease. The IPO cash will fund support its pipeline of IBD drug candidates for specific patient subpopulations.

Aveo Oncology s kidney cancer drug gets FDA nod, 8 years after stinging rejection

Tom Martin, Author at MedCity News

Tom Martin Tom Martin is the director of post-acute care analytics at CarePort, powered by WellSky. He has led several data analytics teams providing insight to healthcare providers trying to improve quality of care for their post-acute care patients. He holds an M.S. in Resources Economics with a concentration in econometrics from the University of Massachusetts Amherst. As director of post-acute care analytics at CarePort, Tom studies how the ever-changing PAC regulatory and payment landscape is impacting care delivery and how acute and post-acute providers can leverage their data to improve patient care.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.